Literature DB >> 19574084

Histopathological analysis of skeletal muscle in patients with Parkinson's disease and 'dropped head'/'bent spine' syndrome.

Hans-Jürgen Gdynia1, Anne-Dorte Sperfeld, Alexander Unrath, Albert C Ludolph, Michael Sabolek, Alexander Storch, Jan Kassubek.   

Abstract

BACKGROUND: 'Dropped head' and 'bent spine' phenomena are recognized clinical presentations of neuromuscular disorders. Similar symptoms are known in patients with parkinsonian syndromes, but their pathophysiology remains unclear. One hypothesis is a relation between the movement disorder and the skeletal muscle pathology.
METHODS: We describe detailed histopathological data from 19 consecutive skeletal muscle biopsies in patients with idiopathic Parkinson's disease (PD) and concomitant 'dropped head' or 'bent spine' syndrome. A biochemical analysis of the respiratory chain complexes was also performed, and clinical, electrophysiological, and imaging data were analyzed.
RESULTS: The subjects developed neuromuscular symptoms 2.7 +/- 2.4 years after onset of PD. We found no correlation with the age at onset of the disease, disease duration, or severity. We found no evidence for dystonia nor did we find any relationship between their anti-parkinsonian medication, and possible drug side effects. Muscle biopsies were abnormal in all patients. Based on histopathological criteria we divided the muscle pathology into three different groups, i.e. necrotizing myopathy, inflammatory myopathy, and myopathy with mitochondrial abnormalities. Biochemical analysis of respiratory chain complexes revealed abnormalities in nine patients.
CONCLUSIONS: 'Dropped head' and 'bent spine' symptoms in association with PD appear to be accompanied by a wide spectrum of histopathological abnormalities in skeletal muscle. A muscle biopsy should be performed to identify potentially treatable conditions (i.e. inflammatory myopathies).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19574084     DOI: 10.1016/j.parkreldis.2009.06.003

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  16 in total

1.  Clinical subtypes of anterocollis in parkinsonian syndromes.

Authors:  Gonzalo J Revuelta; Michael Benatar; Alan Freeman; Thomas Wichmann; H A Jinnah; Mahlon R DeLong; Stewart A Factor
Journal:  J Neurol Sci       Date:  2011-11-30       Impact factor: 3.181

Review 2.  Anterocollis and camptocormia in parkinsonism: a current assessment.

Authors:  Gonzalo J Revuelta
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

3.  An ¹⁸F-FDG PET study of cervical muscle in parkinsonian anterocollis.

Authors:  Gonzalo J Revuelta; Jaime Montilla; Michael Benatar; Alan Freeman; Thomas Wichmann; Hyder A Jinnah; Mahlon R Delong; Stewart A Factor
Journal:  J Neurol Sci       Date:  2014-03-18       Impact factor: 3.181

Review 4.  Therapy-resistant symptoms in Parkinson's disease.

Authors:  Ruxandra Julia Vorovenci; Roberta Biundo; Angelo Antonini
Journal:  J Neural Transm (Vienna)       Date:  2015-09-26       Impact factor: 3.575

5.  Body height loss characterizes camptocormia in Parkinson's disease.

Authors:  Urban M Fietzek; Frauke E Schroeteler; Lisa Hahn; Kerstin Ziegler; Andres O Ceballos-Baumann
Journal:  J Neural Transm (Vienna)       Date:  2018-08-07       Impact factor: 3.575

6.  Neuroprotective effect of treadmill exercise possibly via regulation of lysosomal degradation molecules in mice with pharmacologically induced Parkinson's disease.

Authors:  Dong-Joo Hwang; Jung-Hoon Koo; Ki-Cheon Kwon; Dong-Hoon Choi; Sung-Deuk Shin; Jae-Hoon Jeong; Hyun-Seob Um; Joon-Yong Cho
Journal:  J Physiol Sci       Date:  2017-12-19       Impact factor: 2.781

Review 7.  Dropped head syndrome due to myogenic atrophy - a case report of surgical treatment.

Authors:  Michihisa Zenmyo; Masahiko Abematsu; Takuya Yamamoto; Yasuhiro Ishidou; Setsuro Komiya; Kosei Ijiri
Journal:  Diagn Pathol       Date:  2011-01-19       Impact factor: 2.644

8.  Myofibrillar disorganization characterizes myopathy of camptocormia in Parkinson's disease.

Authors:  Arne Wrede; Nils G Margraf; Hans H Goebel; Günther Deuschl; Walter J Schulz-Schaeffer
Journal:  Acta Neuropathol       Date:  2011-12-11       Impact factor: 17.088

9.  Heat shock protein 90 is a potential therapeutic target for ameliorating skeletal muscle abnormalities in Parkinson's disease.

Authors:  Nour Erekat; Ahed Al-Khatib; Muhammed Al-Jarrah
Journal:  Neural Regen Res       Date:  2014-03-15       Impact factor: 5.135

10.  Axial mitochondrial myopathy in a patient with rapidly progressive adult-onset scoliosis.

Authors:  Annie Hiniker; Lee-Jun Wong; Sigurd Berven; Cavatina K Truong; Adekunle M Adesina; Marta Margeta
Journal:  Acta Neuropathol Commun       Date:  2014-09-16       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.